In another study, miR-26a-5p was also reported to be decreased in AML patients and subsequently the peroxiredoxin III (PrxIII), a reactive oxygen species (ROS) scavenger, was increased (68). The gene discussed is PRDX3; the disease is acute myeloid leukemia.